La Cañada Flintridge, CA, United States of America

Eugene De Juan

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Neovista Inc., Doheny Retina Institute. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugene De Juan. Retrieved from https://idiyas.com/inventor/eugene-de-juan-jq3313d8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eugene de Juan - Pioneering Inventor from La Canada Flintridge, CA

Introduction: Eugene de Juan is a renowned inventor hailing from La Canada Flintridge, CA, known for his groundbreaking contributions to the field of ophthalmology.

Latest Patents: Eugene de Juan holds several patents related to innovative surgical techniques and medical devices in the field of ophthalmology, aimed at improving patient outcomes and revolutionizing eye care.

Career Highlights: Throughout his illustrious career, Eugene de Juan has been a trailblazer in the development of cutting-edge technologies for eye surgeries, earning him recognition as a leading figure in the ophthalmic innovation landscape.

Collaborations: Eugene de Juan has collaborated with top medical institutions, research centers, and fellow inventors to further advance the field of ophthalmology, fostering a culture of innovation and excellence.

Conclusion: Eugene de Juan's dedication to innovation and his pioneering spirit have left an indelible mark on the field of ophthalmology, shaping the future of eye care and improving the lives of countless patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…